Ligand Pharmaceuticals Inc (LGND)
Operating Income Growth
1.74%
Quarterly · Period ending:
LGND Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported1.74%period ending
Latest reported1.74%period ending
LGND Quarterly Operating Income YoY % (26.79% → 1.74%)
Year-over-year change
High-resolution chart · PNG
LGND operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 43.5442% | |
| 21.8204% | |
| 17.547% | |
| 20.8146% | |
| 19.1845% | |
| 15.7402% | |
| 51.046% | |
| 10.6509% | |
| -3.7037% | |
| -0.7937% | |
| -1,157.8947% | |
| -64.0777% | |
| -72.3404% | |
| -38.4615% | |
| 82.0755% | |
| -47.1429% | |
| -5.618% | |
| -49.1803% | |
| -43.2432% | |
| 9.0909% | |
| -264.8148% | |
| -48.7805% | |
| -54.1667% | |
| -60.4167% | |
| 194.7368% | |
| 26.7857% |